Name
Bicara Therapeutics
Company Description
Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class dual action biologics combining the precision of tumor-targeting antibodies with the power of tumor microenvironment modulators. Bicara’s lead program, BCA101, is a first-in-class bifunctional EGFR/TGF-β inhibitor in clinical development for multiple tumor ty
Product Categories (10)
Pharmaceutical
Phone
617-468-4219
Address
116 Huntington Avenue
Suite 703
Boston, MA 02116
LinkedIn
Twitter